Focus: Cancer Center Featured Story 2

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

AACI will host an educational briefing to introduce the 115th Congress, staff, and Hill veterans, to academic cancer centers and highlight the role they play in pursuit of 21st Century Cures.

• share
• favorite_border

Collaborative study with Cleveland Clinic & SUNY Upstate Medical University shows that single high-dose SBRT treatment is as effective as three doses in patients with non-small cell lung cancer

• share
• favorite_border

A summary of a select abstracts by Dana-Farber researchers being presented at 2017 AACR Annual Meeting in April

• share
• favorite_border

New NCCN Guidelines for Patients®: Distress available on NCCN.org/patients

• share
• favorite_border

A University of Colorado Cancer Center study published March 15, 2017 in the journal Melanoma Research uses the unique resource of over 600 melanoma samples collected at the university to demonstrate, for the first time, novel mutations involved in mucosal melanoma, paving the way for therapies to treat this overlooked subtype.

• share
• favorite_border

Researchers at Yale Cancer Center/Smilow Cancer Hospital found that black and Hispanic women in Connecticut are significantly less likely to undergo gene expression profiling than white women.

• share
• favorite_border

In the last 10 years there has been a constant growth in the number of patient with primary liver cancer treated at Yale New Haven Hospital and at Smilow Cancer Hospital. Smilow is one of the few medical center able to offer to patients with primary liver cancer a comprehensive array of therapeutic approaches and personalized care, according to the needs of each patient. These considerations have justified the formation of a freestanding Liver Cancer Program.

• share
• favorite_border

As an institution devoted to eliminating cancer, The University of Texas MD Anderson Cancer Center proudly supports the mission of Kick Butts Day to prevent tobacco use in our nation’s children. Organized by the Campaign for Tobacco-Free Kids (CTFK), Kick Butts Day is a national day of awareness focused on educating and empowering youth to choose tobacco-free lifestyles. Through several evidence-based programs, MD Anderson has committed to educating youth about the dangers of tobacco use and its effects on their future health.

• share
• favorite_border

Highlighting progress and promise in cancer research, including advances made in colorectal cancer, representatives from Rutgers Cancer Institute of New Jersey, American Association of Cancer Research, and University Hospital recently met with Congressman Donald M. Payne, Jr., at Rutgers Cancer Institute of New Jersey at University Hospital in Newark.

• share
• favorite_border

The “Ride for the Cure NM” event is an annual motorcycle ride to raise money and awareness for cancer treatment and research in New Mexico. The ride benefits patient programs and cancer research at The University of New Mexico Comprehensive Cancer Center. The ride started 11 years ago with just 12 riders and has grown to include more than 1,000.

• share
• favorite_border

Moffitt Cancer Center and its community partners will once again host the annual Men’s Health Forum on Saturday, March 18, from 8 a.m.-2:30 p.m. at the University of South Florida Marshall Student Center. This marks the 17th year of the forum and baseball legend Ken Griffey Sr. is scheduled to appear.

• share
• favorite_border

OICR researchers, together with international collaborators, have invented a technique to avoid a major problem with common laboratory techniques and improve the sensitivity of important cancer tests. The findings, published today in the journal Nature Protocols, describe a process by which the sensitivity of DNA sequencing can be improved. The technology, called SiMSen-Seq, could aid in detecting the recurrence of cancers, catching possible disease relapses faster than current methods and improving patient outcomes.

• share
• favorite_border

Latinos experience significant disparities in health care including higher rates of particular cancers, lower cancer screening rates and cancer diagnoses at more advanced stages. Researchers at The University of Kansas Cancer Center want to help Latinos with tobacco cessation treatment (both medication and behavioral support) via text messaging.

• share
• favorite_border

In a new study in the journal Nature, Dana-Farber Cancer Institute scientists report that a compound able to reverse the allegiance of innate immune system cells – turning them from tumor enablers into tumor opponents – caused breast tumors in mice to shrink and withdraw from distant metastases.

• share
• favorite_border

Women at high risk for breast cancer who received a letter informing them of their options for additional imaging with contrast-enhanced MRI of the breast (in addition to a letter sent to their primary care physician) were more likely to return to the center for additional screening with MRI.

• share
• favorite_border

Research by Rutgers University investigators – including a number from Rutgers Cancer Institute of New Jersey – has resulted in the development of small molecule inhibitors that block a protein involved in the development of some cancers. At focus are TAM receptors, which when overexpressed can make too many proteins leading to cancer development, drug resistance and overall poor patient survival.

• share
• favorite_border

• share
• favorite_border

The UNM Comprehensive Cancer Center joined the National Cancer Institute and about 48 other sites to increase colorectal cancer screening rates. Colorectal cancer is one of the few cancer types, of the more than 100 known cancer types, for which screening has been proven to reduce the risk of death.

• share
• favorite_border

Study shows typically ‘mild’ respiratory virus can turn into deadly pneumonia in this vulnerable population, points to need for effective meds, better prevention

• share
• favorite_border

Treatments for childhood cancers have improved to the point that 5-year survival rates are over 80 percent. However, one group has failed to benefit from these improvements, namely children who die so soon after diagnosis that they are not able to receive treatment, or who receive treatment so late in the course of their disease that it is destined to fail.

• share
• favorite_border

Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who were previously considered untreatable. Now, discoveries made by two Cancer Research Institute scientists could help make these and other immunotherapies even more transformative for patients.

• share
• favorite_border

22nd Annual Conference is March 23–25, 2017, in Orlando, FL

• share
• favorite_border

The NCCN Oncology Research Program has awarded grants for its first-ever multi-industry collaborative project, soliciting investigator-initiated proposals to research the effectiveness of Boehringer Ingelheim’s afatinib in combination with other drugs to treat lung and head and neck cancers.

• share
• favorite_border

Researchers from the UC Davis MIND Institute, University of North Carolina (UNC) and other institutions have found that altered distribution of cerebrospinal fluid (CSF) in high-risk infants can predict whether they will develop autism spectrum disorder (ASD). The study appears today in the journal Biological Psychiatry.

• share
• favorite_border

A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy, in cancer survivors, according to a study by researchers at The University of Texas MD Anderson Cancer Center. The pilot study, published in the journal Cancer, is the largest, to date, to determine the benefits of neurofeedback in cancer survivors.

• share
• favorite_border

During cancer treatment, the main focus is on the patient. However, a cancer diagnosis affects the entire family, including caregivers, whose needs often can be overlooked. During this Social Work Month, members of Rutgers Cancer Institute of New Jersey’s Social Work Department share some tips on how caregivers can keep their bodies and minds healthy – without breaking the bank or spending a lot of time – in order to provide the best care for the patient.

• share
• favorite_border

• Team creates calculator to guide treatment choice in esophageal cancer • Tool helps identify which patients may benefit from treatment before surgery • Patients with advanced, aggressive tumors often good pretreatment candidates

• share
• favorite_border

Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.

• share
• favorite_border

A Phase III clinical trial involving 101 centers in 21 countries revealed the monoclonal antibody blinatumomab to be more effective than standard chemotherapy for treatment of advanced acute lymphoblastic leukemia (ALL). Study findings were published in the March 1 online issue of the New England Journal of Medicine.

• share
• favorite_border

Yale scientist Craig M. Crews is the recipient of the 2017 Outstanding Achievement in Chemistry in Cancer Research Award granted by the American Association of Cancer Research (AACR).

• share
• favorite_border

Dr. Kerin Adelson discusses the in-house specialty pharmacy at Smilow Cancer Hospital with HemeOnc Today

• share
• favorite_border

• share
• favorite_border

Blocking a protein found on the surface of ovarian cancer cells could prevent or reduce the spread of the disease to other organs, according to new research at the University of Illinois at Chicago.

• share
• favorite_border

An experimental gene therapy that turns a patient's own blood cells into cancer killers worked in a major study. Article by the Associated Press.

• share
• favorite_border

It’s what’s missing in the tumor genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in Science Translational Medicine.

• share
• favorite_border

Anyone who uses an employee badge to enter a building may understand how a protein called ENL opens new possibilities for treating acute myeloid leukemia (AML), a fast-growing cancer of bone marrow and blood cells and the second most common type of leukemia in children and adults.

• share
• favorite_border

Fred Hutchinson Cancer Research Center today announced the recipients of the Harold M. Weintraub Graduate Student Award, which recognizes the outstanding achievement of graduate studies in the biological sciences. The thirteen award recipients were chosen by a selection committee of Fred Hutch faculty members and students for the quality, originality and significance of their work, and for representation of a diverse range of research topics.

• share
• favorite_border

A research team comprised of members from The University of Kansas Cancer Center, Stowers Institute for Medical Research, and Children’s Mercy are looking at ways to target cancer stem cells to ensure that once a cancer patient goes into remission, they are not at risk of their cancer returning.

• share
• favorite_border

The National Comprehensive Cancer Network® (NCCN®), through funding from the NCCN Foundation® and Kidney Cancer Association, has published a German translation of the NCCN Guidelines for Patients®: Kidney Cancer.

• share
• favorite_border

• Dairy consumption appears to lower risk for breast cancer • High consumption of yogurt linked to reduced risk of breast cancer • Higher intake of some cheeses tied to slightly increased risk

• share
• favorite_border

Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Institute.

• share
• favorite_border

After three rounds of competition — one of which involved a public vote — a software tool developed by researchers at Fred Hutchinson Cancer Research Center and the University of Basel to track Zika, Ebola and other viral disease outbreaks in real time has won the first-ever international Open Science Prize.

• share
• favorite_border

Choosing among cancer treatments increasingly involves determining whether tumor cells harbor specific, mutated “oncogenes” that drive abnormal growth and that may also be especially vulnerable or resistant to particular drugs. But according to a new study led by UCSF researchers, in the case of the most commonly mutated cancer-driving oncogene, called KRAS (pronounced “kay-rass”), response to treatment can change as tumors evolve, either when a normal copy of the gene from the other member of the matched chromosome pair is lost, or when the cancers cells evolve to produce additional copies of the mutated form of the gene.

• share
• favorite_border

Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UC San Francisco, Weill Cornell Medicine and three other medical centers.   A majority of the study’s patients, all women with stage 1 or 2 breast cancer who underwent scalp cooling, retained more than half of their hair after completing chemotherapy, the investigators learned.

• share
• favorite_border

Led by associate professor of pathology and Yale Cancer Center member Don Nguyen, PhD, the researchers analyzed RNA from patients with disease that was limited to the lungs as well as cancers that had spread.

• share
• favorite_border

Susan Baserga selected as a finalist for the 2017 Connecticut Technology Council Women of Innovation program

• share
• favorite_border

Dr. Cary Gross, a professor of medicine and cancer researcher at Yale University School of Medicine discusses his 80-year-old father's diagnosis with Hodgkin’s disease.

• share
• favorite_border

Jeffrey A. Drebin, MD, PhD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Drebin brings to MSK decades of experience as a world-class surgical oncologist specializing in pancreaticobiliary, upper gastrointestinal and liver surgery.